Market Overview:
The global neuro stimulation devices market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to factors such as the increasing prevalence of neurological disorders, technological advancements in neurostimulation devices, and rising demand for minimally invasive procedures. Based on type, the global neurostimulation devices market is segmented into DBS (deep-brain stimulation), VNS (vagus nerve stimulation), RNS (responsive neuro stimulator), TMS (transcranial magnetic stimulator), SCS (spinal cord stimulator) and PNS (peripheral nerve stimulator). DBS held the largest share of the global Neuro Stimulation Devices Market in 2017. This can be attributed to its high efficacy in treating various neurological disorders such as Parkinson’s disease, essential tremor, dystonia and obsessive compulsive disorder. Based on application, pain management held the largest share of the global Neuro Stimulation Devices Market in 2017.
Product Definition:
A neurostimulation device is a medical device that uses electrical current or electromagnetic fields to stimulate the nervous system. Stimulation of the nervous system can be used for therapeutic purposes, such as to reduce pain, or for diagnostic purposes, such as to assess nerve function.
DBS(Deep-Brain Stimulation):
DBS is a therapy used to treat various neurological disorders such as obsessive-compulsive disorder, Parkinson's disease, dystonia and epilepsy. DBS devices are implanted in the brain through surgery; these devices produce regular and mild electrical stimulation for treating the target disorder. The primary goal of DBS therapy is to reduce the frequency of seizures by suppressing neuronal activity in selected regions of the brain.
VNS(Vagus Nerve Stimulation):
VNS is a non-invasive technique that delivers mild electric current to the vagus nerve, which in turn produces feel-good chemicals such as serotonin and endorphins in the brain. The medical device consists of two parts: a generator and an electrode. The generator part is placed inside the body, while the electrode is attached to one’s hand or wrist by a wire.
Application Insights:
The pain management segment dominated the global market in 2017. The rising prevalence of chronic pain is one of the major factors contributing to the growth of this segment. According to a study published in NCBI, around 1/3rd adults experience some form of chronic pain during their lifetime and it was observed that women are more likely to suffer from chronic pains than men. Furthermore, as per another study published by PAINWeekly, majority (around 85%)of patients with acute low back or neck pain had a non-specific symptom onset and did not have an obvious history of trauma or injury. These statistics indicate that there is a high incidence rate for neurostimulation devices for treatment purposes in case if non-specific acute low back or neck pains are considered across various regions globally which further boosts the demand for these devices worldwide.
Pain management using DBS has been gaining significant popularity due largely on technological advancements such as miniaturization.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of neurostimulation device manufacturers and an increase in R&D activities related to neurological disorders. Moreover, rising prevalence of various neurological diseases such as Parkinson’s disease, epilepsy, and others are contributing towards growth in this region. According to Parkinson’s Foundation statistics (2017), around 60 million people worldwide were diagnosed with PD; however, only 1% of these patients live in the U.S.
Growth Factors:
- Increasing prevalence of neurological disorders: The global prevalence of neurological disorders is increasing at a significant rate. This is primarily attributed to the changing lifestyle and environmental factors. According to the World Health Organization (WHO), there are around 350 million people suffering from neurological disorders worldwide. This number is expected to reach nearly 600 million by 2030. This will create a high demand for neurostimulation devices in the coming years.
- Growing awareness about benefits of neurostimulation: There is a growing awareness among people about the benefits of neurostimulation therapy for various neurological conditions such as chronic pain, epilepsy, and Parkinson’s disease. As a result, more people are opting for this treatment option, which is driving the growth of the Neuro Stimulation Devices market globally.
Scope Of The Report
Report Attributes
Report Details
Report Title
Neuro Stimulation Devices Market Research Report
By Type
DBS(Deep-Brain Stimulation), VNS(Vagus Nerve Stimulation), RNS(Responsive Neuro Stimulation), TMS(Transcranial Magnetic Stimulation), SCS(Spinal Cord Stimulation), PNS(Peripheral Nerve Stimulation)
By Application
Pain Management, Parkinson’S Disease, Urinary and Fecal Incontinence, Epilepsy, Hearing Loss, Gastroparesis, Depression, Others
By Companies
Medtronic(U.S), St. Jude Medical(U.S), Boston Scientific(U.S), Cyberonics(U.S), Cochlear(Australia), NDI Medical(U.S), NeuroPace(U.S), ElectroCore Medical(U.S), MED-EL(U.S), Neuronetics(U.S)
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
196
Number of Tables & Figures
138
Customization Available
Yes, the report can be customized as per your need.
Global Neuro Stimulation Devices Market Report Segments:
The global Neuro Stimulation Devices market is segmented on the basis of:
Types
DBS(Deep-Brain Stimulation), VNS(Vagus Nerve Stimulation), RNS(Responsive Neuro Stimulation), TMS(Transcranial Magnetic Stimulation), SCS(Spinal Cord Stimulation), PNS(Peripheral Nerve Stimulation)
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Pain Management, Parkinson’S Disease, Urinary and Fecal Incontinence, Epilepsy, Hearing Loss, Gastroparesis, Depression, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Medtronic(U.S)
- St. Jude Medical(U.S)
- Boston Scientific(U.S)
- Cyberonics(U.S)
- Cochlear(Australia)
- NDI Medical(U.S)
- NeuroPace(U.S)
- ElectroCore Medical(U.S)
- MED-EL(U.S)
- Neuronetics(U.S)
Highlights of The Neuro Stimulation Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- DBS(Deep-Brain Stimulation)
- VNS(Vagus Nerve Stimulation)
- RNS(Responsive Neuro Stimulation)
- TMS(Transcranial Magnetic Stimulation)
- SCS(Spinal Cord Stimulation)
- PNS(Peripheral Nerve Stimulation)
- By Application:
- Pain Management
- Parkinson’S Disease
- Urinary and Fecal Incontinence
- Epilepsy
- Hearing Loss
- Gastroparesis
- Depression
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Neuro Stimulation Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Neurostimulation devices are medical devices that use electrical stimulation to treat conditions such as depression, anxiety, and chronic pain.
Some of the major companies in the neuro stimulation devices market are Medtronic(U.S), St. Jude Medical(U.S), Boston Scientific(U.S), Cyberonics(U.S), Cochlear(Australia), NDI Medical(U.S), NeuroPace(U.S), ElectroCore Medical(U.S), MED-EL(U.S), Neuronetics(U.S).
The neuro stimulation devices market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Neuro Stimulation Devices Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Neuro Stimulation Devices Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Neuro Stimulation Devices Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Neuro Stimulation Devices Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Neuro Stimulation Devices Market Size & Forecast, 2018-2028
4.5.1 Neuro Stimulation Devices Market Size and Y-o-Y Growth
4.5.2 Neuro Stimulation Devices Market Absolute $ Opportunity
Chapter 5 Global Neuro Stimulation Devices Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Neuro Stimulation Devices Market Size Forecast by Type
5.2.1 DBS(Deep-Brain Stimulation)
5.2.2 VNS(Vagus Nerve Stimulation)
5.2.3 RNS(Responsive Neuro Stimulation)
5.2.4 TMS(Transcranial Magnetic Stimulation)
5.2.5 SCS(Spinal Cord Stimulation)
5.2.6 PNS(Peripheral Nerve Stimulation)
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Neuro Stimulation Devices Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Neuro Stimulation Devices Market Size Forecast by Applications
6.2.1 Pain Management
6.2.2 Parkinson’S Disease
6.2.3 Urinary and Fecal Incontinence
6.2.4 Epilepsy
6.2.5 Hearing Loss
6.2.6 Gastroparesis
6.2.7 Depression
6.2.8 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Neuro Stimulation Devices Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Neuro Stimulation Devices Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Neuro Stimulation Devices Analysis and Forecast
9.1 Introduction
9.2 North America Neuro Stimulation Devices Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Neuro Stimulation Devices Market Size Forecast by Type
9.6.1 DBS(Deep-Brain Stimulation)
9.6.2 VNS(Vagus Nerve Stimulation)
9.6.3 RNS(Responsive Neuro Stimulation)
9.6.4 TMS(Transcranial Magnetic Stimulation)
9.6.5 SCS(Spinal Cord Stimulation)
9.6.6 PNS(Peripheral Nerve Stimulation)
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Neuro Stimulation Devices Market Size Forecast by Applications
9.10.1 Pain Management
9.10.2 Parkinson’S Disease
9.10.3 Urinary and Fecal Incontinence
9.10.4 Epilepsy
9.10.5 Hearing Loss
9.10.6 Gastroparesis
9.10.7 Depression
9.10.8 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Neuro Stimulation Devices Analysis and Forecast
10.1 Introduction
10.2 Europe Neuro Stimulation Devices Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Neuro Stimulation Devices Market Size Forecast by Type
10.6.1 DBS(Deep-Brain Stimulation)
10.6.2 VNS(Vagus Nerve Stimulation)
10.6.3 RNS(Responsive Neuro Stimulation)
10.6.4 TMS(Transcranial Magnetic Stimulation)
10.6.5 SCS(Spinal Cord Stimulation)
10.6.6 PNS(Peripheral Nerve Stimulation)
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Neuro Stimulation Devices Market Size Forecast by Applications
10.10.1 Pain Management
10.10.2 Parkinson’S Disease
10.10.3 Urinary and Fecal Incontinence
10.10.4 Epilepsy
10.10.5 Hearing Loss
10.10.6 Gastroparesis
10.10.7 Depression
10.10.8 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Neuro Stimulation Devices Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Neuro Stimulation Devices Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Neuro Stimulation Devices Market Size Forecast by Type
11.6.1 DBS(Deep-Brain Stimulation)
11.6.2 VNS(Vagus Nerve Stimulation)
11.6.3 RNS(Responsive Neuro Stimulation)
11.6.4 TMS(Transcranial Magnetic Stimulation)
11.6.5 SCS(Spinal Cord Stimulation)
11.6.6 PNS(Peripheral Nerve Stimulation)
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Neuro Stimulation Devices Market Size Forecast by Applications
11.10.1 Pain Management
11.10.2 Parkinson’S Disease
11.10.3 Urinary and Fecal Incontinence
11.10.4 Epilepsy
11.10.5 Hearing Loss
11.10.6 Gastroparesis
11.10.7 Depression
11.10.8 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Neuro Stimulation Devices Analysis and Forecast
12.1 Introduction
12.2 Latin America Neuro Stimulation Devices Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Neuro Stimulation Devices Market Size Forecast by Type
12.6.1 DBS(Deep-Brain Stimulation)
12.6.2 VNS(Vagus Nerve Stimulation)
12.6.3 RNS(Responsive Neuro Stimulation)
12.6.4 TMS(Transcranial Magnetic Stimulation)
12.6.5 SCS(Spinal Cord Stimulation)
12.6.6 PNS(Peripheral Nerve Stimulation)
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Neuro Stimulation Devices Market Size Forecast by Applications
12.10.1 Pain Management
12.10.2 Parkinson’S Disease
12.10.3 Urinary and Fecal Incontinence
12.10.4 Epilepsy
12.10.5 Hearing Loss
12.10.6 Gastroparesis
12.10.7 Depression
12.10.8 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Neuro Stimulation Devices Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Neuro Stimulation Devices Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Neuro Stimulation Devices Market Size Forecast by Type
13.6.1 DBS(Deep-Brain Stimulation)
13.6.2 VNS(Vagus Nerve Stimulation)
13.6.3 RNS(Responsive Neuro Stimulation)
13.6.4 TMS(Transcranial Magnetic Stimulation)
13.6.5 SCS(Spinal Cord Stimulation)
13.6.6 PNS(Peripheral Nerve Stimulation)
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Neuro Stimulation Devices Market Size Forecast by Applications
13.10.1 Pain Management
13.10.2 Parkinson’S Disease
13.10.3 Urinary and Fecal Incontinence
13.10.4 Epilepsy
13.10.5 Hearing Loss
13.10.6 Gastroparesis
13.10.7 Depression
13.10.8 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Neuro Stimulation Devices Market: Competitive Dashboard
14.2 Global Neuro Stimulation Devices Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Medtronic(U.S)
14.3.2 St. Jude Medical(U.S)
14.3.3 Boston Scientific(U.S)
14.3.4 Cyberonics(U.S)
14.3.5 Cochlear(Australia)
14.3.6 NDI Medical(U.S)
14.3.7 NeuroPace(U.S)
14.3.8 ElectroCore Medical(U.S)
14.3.9 MED-EL(U.S)
14.3.10 Neuronetics(U.S)
